Occlusion of the middle cerebral artery and thrombosis of the superior sagittal sinus are reported in a 30-year-old woman taking oral contraceptives (OC). The coexistence of arterial and venous cerebral pathology as a complication of OC use has only been previously reported in one case. The pathogenesis of this rare association is briefly discussed.
Introduction
The risk of ischaemic stroke has consistently been found to be increased among current users of oral contraceptives (OC) (Collaborative group for the Study of Stroke in Young Women, 1973 and 1975) . In addition, intracranial venous thrombosis has also been associated with the use of OC (Rousseaux et al., 1977; Navarro et aL, 1978) . However, the simultaneous occurrence of both complications in patients using OC has been reported in only one previous case (Walsh et aL, 1965) . Here we describe a middle cerebral artery occlusion followed by superior sagittal sinus thrombosis in a young woman who had been taking OC.
Case report
This 30-year-old woman had been taking OC (Eugynon®: norgestrel 0-5 mg; ethinyloestradiol 0 05 mg) for 4 years for contraceptive purposes. She developed-a headache and left hemiparesis over a period of 2 hr. On admission, in June 1980, she had left hemiplegia, hemihypoesthesia and homonymous hemianopsia. Her blood pressure was 120/70 mm Hg. The next day a right carotid angiogram showed a complete occlusion ofthe middle cerebral artery at its origin, the venous phase being normal ( Fig. la & b ). An electroencephalogram (EEG) revealed focal low frequency delta activity in the right frontotemporal region, with preservation of alpha rhythm posteriorly and in the left hemisphere. Routine haematological and biochemical screening examinations were unremarkable except for a slightly raised blood cholesteroL 332 mg/100 ml (normal up to 250 mg/100 ml) and triglycerides 237 mg/100 ml (normal up to 150-160 mg/100 ml). Serological studies for systemic lupus erythematosus and syphilis, coagulation proffile including antithrombin III level, electrocardiogram and cardiological study, cerebrospinal fluid (CSF) examination and chest X-ray were all normal.
Two days after admission, the headache worsened, with nausea and vomiting. Intravenous dexamethasone 4 mg every 6 hr was commenced. Her clinical condition improved rapidly over the next 72 hr, until only a slight left hemiparesis remained. Dexamethasone treatment was tapered off 7 days later. On the 20th day of hospitalization, a severe, persistent rightsided headache began, accompanied by profuse vomiting. On examination, there was papilloedema, neck stiffness and an increased left hemiparesis. On the EEG, together with the focal delta activity in the right frontotemporal region, there was now a diffuse slowing of the basic rhythms. A computerized tomography (CT) scan showed a well-defined infarct hypodensity involving the right anterior capsulebasal ganglia region with enlargement of the right frontal horn; signs of superior sagittal sinus thrombosis (Lee and Rao, 1983) were not observed. A left carotid angiogram disclosed slowing of the circulation and occlusion of almost the entire superior sagittal sinus ( Fig. lc and 2 ). Treatment with dexamethasone was renewed for 1 month. The patient improved rapidly over the course ofthe next 3 weeks. Cholesterol and triglyceride levels were normal on repeated testing. Two 
Discussion
Th-e clinical course of our patient was in two phases. The initial clinical manifestations are entirely compatible with the occlusion of the middle cerebral artery and the capsular infarct, demonstrated in the right carotid angiogram and CT scan respectively. The signs and symptoms as well as the electroencephalogram anomalies in both hemispheres which had developed 3 weeks later correlate well with the saggital sinus thrombosis on the left carotid angiogram (Kalbag and Woolf, 1972) . The only risk factors of either arterial or venous cerebrovascular disease were the use of OC and the raised levels of cholesterol and triglycerides, such as those described during OC use (Wallace et aL, 1979; Oster et al., 1982) . Other possible aetiologies considered in the differential diagnosis of cerebral infarction in young adults (Hart and Miller, 1983) and intracranial phlebothrombosis (Estanol et aL, 1979) could reasonably be excluded in our patient.
The association of intracranial arterial and venous thrombosis in women OC users, as in the case we report here, has been previously described only in Case 1 of the series of Walsh et al. (1965) . In their patient, the arteriogram showed an almost complete obstruction of the left carotid artery. On postmortem examination there was evidence of obstruction of both internal carotid arteries and venous thromboses were present in the left ophthalmic vein, all of the dural sinuses and the cerebral cortical veins. It remains to be clarified whether this association is due to the development of intracranial phlebothrombosis as a complication of cerebral arterial occlusion (Kalberg and Woolf., 1972; Barnett and Hyland, 1953) or to systemic arterial and venous vasculopathy induced by OC (Basdevant, Ligni6res and MauvaisJarvis, 1980; Irey, McAllister and Henry, 1978) .
